The search for cis-regulatory driver mutations in cancer genomes
Metrics: PDF 2268 views | HTML 2560 views | ?
Rebecca C. Poulos1, Mathew A. Sloane1, Luke B. Hesson1, Jason W. H. Wong1
1Prince of Wales Clinical School and Lowy Cancer Research Centre, UNSW Australia, Sydney, Australia
Rebecca C. Poulos, e-mail: email@example.com
Jason W. H. Wong, e-mail: firstname.lastname@example.org
Keywords: promoter, enhancer, cancer, somatic mutation, cis-regulation
Received: June 11, 2015 Accepted: August 06, 2015 Published: August 20, 2015
With the advent of high-throughput and relatively inexpensive whole-genome sequencing technology, the focus of cancer research has begun to shift toward analyses of somatic mutations in non-coding cis-regulatory elements of the cancer genome. Cis-regulatory elements play an important role in gene regulation, with mutations in these elements potentially resulting in changes to the expression of linked genes. The recent discoveries of recurrent TERT promoter mutations in melanoma, and recurrent mutations that create a super-enhancer regulating TAL1 expression in T-cell acute lymphoblastic leukaemia (T-ALL), have sparked significant interest in the search for other somatic cis-regulatory mutations driving cancer development. In this review, we look more closely at the TERT promoter and TAL1 enhancer alterations and use these examples to ask whether other cis-regulatory mutations may play a role in cancer susceptibility. In doing so, we make observations from the data emerging from recent research in this field, and describe the experimental and analytical approaches which could be adopted in the hope of better uncovering the true functional significance of somatic cis-regulatory mutations in cancer.
All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.